Focus on... Linezolid: a synthetic oxazolidinone antimicrobial for treatment of serious gram-positive infections.
- Published in:
- 2000
- By:
- Publication type:
- Journal Article
Works matching IS 1082801X AND DT 2000 AND VI 35 AND IP 6
Results: 18
1
2
Practical pharmacoeconomics. Use of decision analysis in modeling the cost-effectiveness of oral vs SC sumatriptan.
- Published in:
- 2000
- By:
- Publication type:
- Journal Article
3
Parenteral iron products for anemia in end-stage renal disease: comparative considerations.
- Published in:
- 2000
- By:
- Publication type:
- Journal Article
4
Scorecard. New antiarthritics post gains across the board, Levaquin challenges Cipro among quinolones.
- Published in:
- 2000
- Publication type:
- Journal Article
5
Drugs for selected GI disorders.
- Published in:
- Formulary, 2000, v. 35, n. 6, p. 544
- Publication type:
- Article
6
Policymakers, insurers decry drug prices, study factors driving spending growth.
- Published in:
- Formulary, 2000, v. 35, n. 6, p. 542
- By:
- Publication type:
- Article
7
Multidisciplinary team-led initiative improves preoperative antibiotic administration time.
- Published in:
- Formulary, 2000, v. 35, n. 6, p. 541
- Publication type:
- Article
8
Sildenafil: Identifying and correcting inappropriate use in a state Medicaid population.
- Published in:
- Formulary, 2000, v. 35, n. 6, p. 540
- Publication type:
- Article
9
Protease inhibitor use reduces AIDS therapy costs, opportunistic infections.
- Published in:
- Formulary, 2000, v. 35, n. 6, p. 540
- Publication type:
- Article
10
Use of decision analysis in modeling the cost-effectiveness of oral vs SC sumatriptan.
- Published in:
- Formulary, 2000, v. 35, n. 6, p. 532
- By:
- Publication type:
- Article
11
Regence BlueShield's mandatory data submission requirement for manufacturers: A progress report.
- Published in:
- 2000
- By:
- Publication type:
- Interview
12
Parenteral iron products for anemia in end-stage renal disease: Comparative considerations.
- Published in:
- Formulary, 2000, v. 35, n. 6, p. 498
- By:
- Publication type:
- Article
13
Linezolid.
- Published in:
- Formulary, 2000, v. 35, n. 6, p. 483
- By:
- Publication type:
- Article
14
Long-term trial finds fewer serious GI effects with COX-2 inhibitor than with traditional NSAIDs.
- Published in:
- Formulary, 2000, v. 35, n. 6, p. 480
- Publication type:
- Article
15
Consensus report updates guidelines for pharmacologic Tx of bipolar disorder.
- Published in:
- Formulary, 2000, v. 35, n. 6, p. 479
- Publication type:
- Article
16
NSAIDs raise risk of hospitalization for CHF.
- Published in:
- Formulary, 2000, v. 35, n. 6, p. 479
- Publication type:
- Article
17
FDA Drug Approvals.
- Published in:
- Formulary, 2000, v. 35, n. 6, p. 471
- Publication type:
- Article
18
New antiarthritics post gains across the board, Levaquin challenges Cipro among quinolones.
- Published in:
- Formulary, 2000, v. 35, n. 6, p. 467
- Publication type:
- Article